XINT Q2 2026 higher sales, XSTEM clinical progress, stronger financing
XINT reported Q2 2026 higher sales, clinical progress for XSTEM, and strengthened financing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.